We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

These Immune Players Deserve More Time in the Limelight

News   Sep 21, 2018 | By Heather Buschman, PhD for UC San Diego Health

 
Cancer Immunotherapy Might Benefit From Previously Overlooked Immune Players

Major Histocompatibility Complex (MHC) molecules display antigens to T cells, immune cells that constantly check for infected or damaged cells. If T cells spot MHC molecules with foreign antigens or mutated self-antigens (such as cancer antigens), they kill the cell before the damage spreads. MHC-II is only displayed by professional immune cells, such as macrophages, and is recognized by CD4+ T cells. MHC-I is displayed on the surface of every cell, and thus any cell with the potential to become cancerous, and is recognized by CD8+ T cells. Credit: UC San Diego Health

 
 
Advertisement
 

RELATED ARTICLES

Presence of a Specific Bacterium Linked to IBS

News

Researchers have detected a connection between Brachyspira, a genus of bacteria in the intestines, and IBS.

READ MORE

How the CRISPR Immune System Evolved

News

New research results shed new light on how CRISPR-Cas emerged early during the development of life on Earth, as well as how this immune system is constantly adapting to new challenges.

READ MORE

What Causes Influenza Infections To Become Deadly?

News

It is largely unknown why influenza infections lead to an increased risk of bacterial pneumonia. However, researchers have now described important findings leading to so-called superinfections, which claim many lives around the world every year.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE